Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 232,781 | 187,891 | 252,398 | 355,968 | 35,966 |
| Marketable Securities | 493,344 | 544,684 | 691,013 | 79,672 | N/A |
| Receivables | 13,912 | 13,286 | 315 | N/A | N/A |
| TOTAL | $753,354 | $772,332 | $951,839 | $439,235 | $36,125 |
| Non-Current Assets | |||||
| PPE Net | 133,110 | 81,734 | 42,086 | 4,018 | 40 |
| Investments And Advances | 247,735 | 189,706 | 272,888 | 38,411 | 0 |
| Intangibles | 296,563 | 299,292 | 172,269 | 0 | 0 |
| Other Non-Current Assets | 4,074 | 6,400 | 6,046 | 7,499 | 3,929 |
| TOTAL | $681,482 | $577,132 | $493,289 | $49,928 | $3,969 |
| Total Assets | $1,434,836 | $1,349,464 | $1,445,128 | $489,163 | $40,094 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,416 | 4,415 | 4,248 | 1,096 | 1,148 |
| Accrued Expenses | 81,244 | 36,822 | 33,376 | 14,577 | 9,970 |
| Other current liabilities | 93,763 | 30,391 | 66,734 | 84,920 | N/A |
| TOTAL | $208,752 | $114,892 | $119,728 | $100,593 | $11,118 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,945 | 0 | N/A | N/A | N/A |
| Deferred Revenues | 21,329 | 43,264 | 15,370 | N/A | N/A |
| Other Non-Current Liabilities | 22,656 | 13,291 | 35,796 | 38 | 75 |
| TOTAL | $179,102 | $156,871 | $183,867 | $38 | $75 |
| Total Liabilities | $387,854 | $271,763 | $303,595 | $100,631 | $11,193 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,105 | 106,020 | 104,060 | N/A | 77,939 |
| Common Shares | 12 | 11 | 10 | 8 | 1 |
| Retained earnings | -1,268,343 | -831,237 | -585,657 | -346,281 | -51,820 |
| Other shareholders' equity | 3,421 | -2,842 | -6,083 | -90 | 72,583 |
| TOTAL | $1,046,982 | $1,077,701 | $1,141,533 | $388,532 | $28,901 |
| Total Liabilities And Equity | $1,434,836 | $1,349,464 | $1,445,128 | $489,163 | $40,094 |